Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 66 | 2024 | 1271 | 15.140 |
Why?
|
Subarachnoid Hemorrhage | 51 | 2024 | 1023 | 13.770 |
Why?
|
Aneurysm, Ruptured | 39 | 2024 | 455 | 13.470 |
Why?
|
Central Nervous System Vascular Malformations | 22 | 2024 | 141 | 6.070 |
Why?
|
Intracranial Arteriovenous Malformations | 24 | 2024 | 360 | 6.030 |
Why?
|
Vasospasm, Intracranial | 14 | 2024 | 207 | 4.510 |
Why?
|
Moyamoya Disease | 13 | 2024 | 274 | 4.210 |
Why?
|
Cerebral Revascularization | 11 | 2024 | 260 | 3.500 |
Why?
|
Cerebral Angiography | 33 | 2022 | 1263 | 3.080 |
Why?
|
Neurosurgical Procedures | 24 | 2024 | 2077 | 2.950 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 7 | 2023 | 58 | 2.560 |
Why?
|
Embolization, Therapeutic | 25 | 2024 | 1403 | 2.500 |
Why?
|
Anterior Cerebral Artery | 5 | 2021 | 50 | 2.430 |
Why?
|
Arteriovenous Malformations | 6 | 2014 | 396 | 2.000 |
Why?
|
Basilar Artery | 5 | 2021 | 207 | 1.980 |
Why?
|
Brain Ischemia | 16 | 2024 | 3001 | 1.810 |
Why?
|
Middle Cerebral Artery | 5 | 2023 | 271 | 1.750 |
Why?
|
Microsurgery | 9 | 2024 | 798 | 1.580 |
Why?
|
Carotid Artery, Internal | 5 | 2024 | 440 | 1.380 |
Why?
|
Cerebral Hemorrhage | 14 | 2024 | 2654 | 1.380 |
Why?
|
Angiography, Digital Subtraction | 11 | 2022 | 331 | 1.340 |
Why?
|
Posterior Cerebral Artery | 4 | 2015 | 35 | 1.180 |
Why?
|
Cerebrovascular Disorders | 7 | 2018 | 1478 | 1.160 |
Why?
|
Endovascular Procedures | 13 | 2024 | 2215 | 1.120 |
Why?
|
Circle of Willis | 4 | 2023 | 77 | 1.110 |
Why?
|
Arteriovenous Fistula | 4 | 2022 | 320 | 1.100 |
Why?
|
Hemangioma, Cavernous | 3 | 2023 | 106 | 1.010 |
Why?
|
Middle Aged | 105 | 2024 | 223267 | 1.000 |
Why?
|
Radiosurgery | 11 | 2024 | 1330 | 1.000 |
Why?
|
Adult | 97 | 2024 | 223305 | 0.940 |
Why?
|
Magnesium | 2 | 2018 | 815 | 0.940 |
Why?
|
Female | 130 | 2024 | 396532 | 0.940 |
Why?
|
Male | 127 | 2024 | 364154 | 0.930 |
Why?
|
Stroke | 18 | 2024 | 9744 | 0.910 |
Why?
|
Humans | 195 | 2024 | 766812 | 0.890 |
Why?
|
Aneurysm | 2 | 2018 | 343 | 0.880 |
Why?
|
Aspirin | 5 | 2024 | 3134 | 0.860 |
Why?
|
Aged | 75 | 2024 | 171344 | 0.850 |
Why?
|
Sirtuin 1 | 1 | 2024 | 247 | 0.840 |
Why?
|
Risk Factors | 45 | 2024 | 74889 | 0.820 |
Why?
|
rho-Associated Kinases | 1 | 2024 | 290 | 0.820 |
Why?
|
Administration, Intranasal | 1 | 2024 | 482 | 0.810 |
Why?
|
Veins | 2 | 2023 | 769 | 0.800 |
Why?
|
Intracranial Hemorrhages | 6 | 2022 | 810 | 0.770 |
Why?
|
Craniotomy | 4 | 2017 | 736 | 0.720 |
Why?
|
Patient Readmission | 4 | 2019 | 3283 | 0.710 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 519 | 0.710 |
Why?
|
Hemorrhage | 5 | 2013 | 3464 | 0.700 |
Why?
|
Central Nervous System | 2 | 2023 | 1345 | 0.650 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2021 | 270 | 0.630 |
Why?
|
Retrospective Studies | 51 | 2024 | 81657 | 0.630 |
Why?
|
Imaging, Three-Dimensional | 10 | 2022 | 4047 | 0.620 |
Why?
|
Treatment Outcome | 51 | 2024 | 65286 | 0.610 |
Why?
|
Estrogens | 1 | 2024 | 1528 | 0.580 |
Why?
|
Heroin | 1 | 2018 | 120 | 0.560 |
Why?
|
Estradiol | 1 | 2024 | 1947 | 0.560 |
Why?
|
Endarterectomy, Carotid | 2 | 2019 | 556 | 0.560 |
Why?
|
Seizures | 7 | 2022 | 2996 | 0.550 |
Why?
|
Angiopoietin-1 | 2 | 2015 | 132 | 0.550 |
Why?
|
Logistic Models | 12 | 2020 | 13276 | 0.550 |
Why?
|
Spinal Cord Vascular Diseases | 2 | 2013 | 10 | 0.540 |
Why?
|
Heroin Dependence | 1 | 2017 | 173 | 0.540 |
Why?
|
Multivariate Analysis | 11 | 2020 | 12064 | 0.540 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.540 |
Why?
|
Cross Infection | 2 | 2016 | 1427 | 0.540 |
Why?
|
Postoperative Complications | 12 | 2024 | 15831 | 0.530 |
Why?
|
Case-Control Studies | 12 | 2024 | 22248 | 0.530 |
Why?
|
Smoking | 7 | 2024 | 9077 | 0.520 |
Why?
|
Hypoglycemic Agents | 2 | 2020 | 3108 | 0.510 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 2763 | 0.510 |
Why?
|
Cerebral Arterial Diseases | 2 | 2013 | 82 | 0.510 |
Why?
|
Endothelial Cells | 3 | 2024 | 3582 | 0.500 |
Why?
|
Cerebral Arteries | 3 | 2013 | 490 | 0.500 |
Why?
|
Rupture, Spontaneous | 5 | 2018 | 365 | 0.490 |
Why?
|
Automobile Driving | 1 | 2020 | 442 | 0.490 |
Why?
|
Papaverine | 1 | 2015 | 44 | 0.490 |
Why?
|
Mydriasis | 1 | 2015 | 13 | 0.480 |
Why?
|
Meteorological Concepts | 1 | 2014 | 30 | 0.480 |
Why?
|
Calcium | 2 | 2018 | 5783 | 0.480 |
Why?
|
Tomography, X-Ray Computed | 15 | 2024 | 20710 | 0.480 |
Why?
|
Neurosurgery | 5 | 2015 | 682 | 0.480 |
Why?
|
Aortic Rupture | 1 | 2018 | 322 | 0.470 |
Why?
|
Nanoparticles | 2 | 2024 | 1966 | 0.470 |
Why?
|
Tracheostomy | 1 | 2018 | 430 | 0.460 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2024 | 484 | 0.460 |
Why?
|
Hypopituitarism | 1 | 2016 | 253 | 0.460 |
Why?
|
Hyponatremia | 1 | 2016 | 278 | 0.440 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.430 |
Why?
|
Pia Mater | 1 | 2013 | 85 | 0.420 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2013 | 37 | 0.420 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9528 | 0.420 |
Why?
|
Ophthalmic Artery | 1 | 2013 | 57 | 0.410 |
Why?
|
Cerebral Infarction | 6 | 2021 | 968 | 0.410 |
Why?
|
Temporal Arteries | 2 | 2023 | 155 | 0.410 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 319 | 0.410 |
Why?
|
Telangiectasis | 1 | 2012 | 78 | 0.400 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.390 |
Why?
|
Carotid Artery Diseases | 3 | 2024 | 872 | 0.390 |
Why?
|
Cohort Studies | 17 | 2024 | 41706 | 0.380 |
Why?
|
Aged, 80 and over | 23 | 2024 | 59548 | 0.380 |
Why?
|
Natural Language Processing | 2 | 2020 | 1203 | 0.380 |
Why?
|
Sclerosis | 1 | 2012 | 211 | 0.380 |
Why?
|
Hydrocephalus | 4 | 2017 | 766 | 0.380 |
Why?
|
Anticoagulants | 2 | 2018 | 4854 | 0.380 |
Why?
|
Rupture | 1 | 2013 | 444 | 0.380 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.370 |
Why?
|
North America | 3 | 2022 | 1287 | 0.370 |
Why?
|
Laminectomy | 1 | 2012 | 226 | 0.370 |
Why?
|
Fever | 1 | 2018 | 1607 | 0.360 |
Why?
|
Spinal Cord Diseases | 2 | 2013 | 291 | 0.360 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2252 | 0.360 |
Why?
|
Anticonvulsants | 3 | 2022 | 1921 | 0.350 |
Why?
|
Neovascularization, Pathologic | 4 | 2008 | 2631 | 0.350 |
Why?
|
Iron | 1 | 2019 | 1812 | 0.350 |
Why?
|
Vasodilator Agents | 1 | 2015 | 988 | 0.350 |
Why?
|
Headache | 2 | 2015 | 1260 | 0.350 |
Why?
|
Odds Ratio | 6 | 2021 | 9661 | 0.350 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2744 | 0.340 |
Why?
|
Software | 3 | 2019 | 4464 | 0.340 |
Why?
|
Warfarin | 1 | 2018 | 1493 | 0.340 |
Why?
|
Propensity Score | 4 | 2024 | 1972 | 0.330 |
Why?
|
Inpatients | 4 | 2024 | 2566 | 0.330 |
Why?
|
Disease Progression | 3 | 2024 | 13642 | 0.330 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 418 | 0.330 |
Why?
|
Ear, Inner | 1 | 2013 | 426 | 0.320 |
Why?
|
Prevalence | 4 | 2021 | 15835 | 0.320 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 804 | 0.320 |
Why?
|
Adolescent | 28 | 2024 | 88902 | 0.320 |
Why?
|
Dilatation, Pathologic | 2 | 2024 | 527 | 0.320 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12808 | 0.320 |
Why?
|
Clostridium Infections | 1 | 2016 | 563 | 0.320 |
Why?
|
Hospital Mortality | 5 | 2017 | 5344 | 0.320 |
Why?
|
Young Adult | 21 | 2024 | 59939 | 0.310 |
Why?
|
Hospitals, General | 1 | 2013 | 804 | 0.310 |
Why?
|
Magnetic Resonance Angiography | 3 | 2021 | 1428 | 0.310 |
Why?
|
Sex Characteristics | 1 | 2019 | 2645 | 0.310 |
Why?
|
Incidence | 10 | 2024 | 21527 | 0.310 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1156 | 0.310 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2010 | 123 | 0.310 |
Why?
|
MicroRNAs | 1 | 2024 | 3789 | 0.310 |
Why?
|
Reflex, Pupillary | 2 | 2005 | 63 | 0.300 |
Why?
|
Immunoglobulins | 1 | 2011 | 853 | 0.300 |
Why?
|
Petrous Bone | 3 | 2012 | 85 | 0.300 |
Why?
|
Disease Management | 2 | 2015 | 2533 | 0.290 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18329 | 0.290 |
Why?
|
Radiculopathy | 1 | 2010 | 202 | 0.290 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1029 | 0.290 |
Why?
|
Aorta | 1 | 2015 | 2043 | 0.280 |
Why?
|
Stress, Physiological | 1 | 2015 | 1407 | 0.280 |
Why?
|
Age Factors | 9 | 2024 | 18397 | 0.280 |
Why?
|
Comorbidity | 8 | 2017 | 10580 | 0.280 |
Why?
|
Spine | 1 | 2014 | 1134 | 0.270 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 926 | 0.270 |
Why?
|
Vascular Surgical Procedures | 3 | 2015 | 1506 | 0.270 |
Why?
|
Risk Assessment | 5 | 2019 | 24299 | 0.270 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1514 | 0.260 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36570 | 0.260 |
Why?
|
Decompressive Craniectomy | 2 | 2017 | 76 | 0.260 |
Why?
|
Quality of Health Care | 2 | 2019 | 4306 | 0.260 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39312 | 0.260 |
Why?
|
Length of Stay | 5 | 2019 | 6491 | 0.250 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 461 | 0.250 |
Why?
|
Time Factors | 10 | 2024 | 40149 | 0.250 |
Why?
|
Contrast Media | 2 | 2022 | 5329 | 0.250 |
Why?
|
Smoking Cessation | 1 | 2017 | 2085 | 0.250 |
Why?
|
Hemodynamics | 1 | 2016 | 4188 | 0.250 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2008 | 633 | 0.250 |
Why?
|
Insulin | 1 | 2020 | 6608 | 0.240 |
Why?
|
Blood Glucose | 1 | 2020 | 6422 | 0.240 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 141 | 0.240 |
Why?
|
Estriol | 1 | 2024 | 53 | 0.240 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4249 | 0.240 |
Why?
|
Spinal Cord | 2 | 2012 | 1811 | 0.230 |
Why?
|
Sex Distribution | 3 | 2015 | 2274 | 0.230 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15912 | 0.230 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.230 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 627 | 0.220 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2010 | 713 | 0.220 |
Why?
|
Age Distribution | 3 | 2015 | 2869 | 0.220 |
Why?
|
Risk | 5 | 2020 | 9602 | 0.220 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11514 | 0.220 |
Why?
|
Trochlear Nerve | 1 | 2003 | 26 | 0.210 |
Why?
|
Trochlear Nerve Diseases | 1 | 2003 | 15 | 0.210 |
Why?
|
Calcium Phosphates | 1 | 2024 | 172 | 0.210 |
Why?
|
Linear Models | 3 | 2019 | 5873 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2021 | 8928 | 0.210 |
Why?
|
Cranial Nerves | 1 | 2023 | 97 | 0.210 |
Why?
|
Indenes | 1 | 2023 | 59 | 0.210 |
Why?
|
Neoplasm Invasiveness | 2 | 2008 | 3610 | 0.210 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2005 | 252 | 0.210 |
Why?
|
Glioblastoma | 2 | 2008 | 3458 | 0.210 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2971 | 0.210 |
Why?
|
Cerebrovascular Trauma | 1 | 2022 | 21 | 0.200 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8045 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3250 | 0.200 |
Why?
|
Cardiomyopathies | 1 | 2015 | 2058 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3360 | 0.200 |
Why?
|
Trigeminal Neuralgia | 1 | 2003 | 103 | 0.200 |
Why?
|
Insurance Coverage | 1 | 2013 | 1945 | 0.200 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2003 | 131 | 0.200 |
Why?
|
Cavernous Sinus | 1 | 2003 | 121 | 0.200 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2024 | 557 | 0.190 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 2671 | 0.190 |
Why?
|
Brain Neoplasms | 4 | 2016 | 9101 | 0.190 |
Why?
|
Carotid Stenosis | 2 | 2019 | 858 | 0.190 |
Why?
|
Dura Mater | 1 | 2023 | 292 | 0.190 |
Why?
|
Temporal Lobe | 2 | 2012 | 1716 | 0.190 |
Why?
|
Intraoperative Care | 1 | 2005 | 768 | 0.190 |
Why?
|
Aneurysm, Infected | 1 | 2022 | 82 | 0.190 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1733 | 0.190 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 1946 | 0.180 |
Why?
|
Radiography | 4 | 2015 | 6968 | 0.180 |
Why?
|
United States | 12 | 2024 | 72945 | 0.180 |
Why?
|
Transverse Sinuses | 1 | 2021 | 25 | 0.180 |
Why?
|
Proteins | 1 | 2015 | 6002 | 0.180 |
Why?
|
Infarction | 1 | 2022 | 247 | 0.180 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2413 | 0.170 |
Why?
|
Registries | 3 | 2021 | 8352 | 0.170 |
Why?
|
Hospital Bed Capacity | 2 | 2018 | 200 | 0.170 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 649 | 0.160 |
Why?
|
Hospitalization | 2 | 2016 | 10816 | 0.160 |
Why?
|
Brain | 3 | 2024 | 27158 | 0.160 |
Why?
|
Models, Biological | 2 | 2015 | 9464 | 0.160 |
Why?
|
Vascular System Injuries | 1 | 2022 | 247 | 0.160 |
Why?
|
Interdisciplinary Communication | 1 | 2005 | 932 | 0.160 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.150 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.150 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4712 | 0.150 |
Why?
|
Hemifacial Spasm | 1 | 2018 | 23 | 0.150 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 670 | 0.150 |
Why?
|
Vitamin D | 1 | 2011 | 3270 | 0.150 |
Why?
|
Child | 14 | 2023 | 80670 | 0.150 |
Why?
|
Neurilemmoma | 1 | 2003 | 522 | 0.150 |
Why?
|
Epilepsy | 3 | 2022 | 3317 | 0.140 |
Why?
|
Surgical Instruments | 3 | 2018 | 379 | 0.140 |
Why?
|
Epithelial Cells | 2 | 2024 | 3698 | 0.140 |
Why?
|
Optic Nerve Diseases | 1 | 2021 | 342 | 0.140 |
Why?
|
Computational Biology | 1 | 2009 | 3564 | 0.140 |
Why?
|
Neuroprotective Agents | 1 | 2023 | 956 | 0.140 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2005 | 949 | 0.140 |
Why?
|
Cell Movement | 2 | 2024 | 5204 | 0.130 |
Why?
|
Ferritins | 1 | 2019 | 601 | 0.130 |
Why?
|
Databases, Factual | 4 | 2017 | 8065 | 0.130 |
Why?
|
Asthma | 2 | 2012 | 6266 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2013 | 6214 | 0.130 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12536 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2262 | 0.120 |
Why?
|
Hospital Charges | 1 | 2017 | 345 | 0.120 |
Why?
|
Models, Neurological | 2 | 2014 | 1747 | 0.120 |
Why?
|
Mice | 10 | 2024 | 81898 | 0.120 |
Why?
|
Area Under Curve | 2 | 2016 | 1639 | 0.120 |
Why?
|
Oligonucleotides | 1 | 2018 | 561 | 0.120 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 367 | 0.120 |
Why?
|
Prognosis | 5 | 2021 | 29959 | 0.120 |
Why?
|
Animals | 14 | 2024 | 168939 | 0.120 |
Why?
|
Oculomotor Nerve | 1 | 2015 | 72 | 0.120 |
Why?
|
Melanins | 1 | 2017 | 291 | 0.120 |
Why?
|
Mice, Inbred DBA | 1 | 2015 | 624 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2023 | 1851 | 0.120 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 456 | 0.110 |
Why?
|
Piracetam | 1 | 2014 | 88 | 0.110 |
Why?
|
Meningioma | 2 | 2015 | 1221 | 0.110 |
Why?
|
Phenytoin | 1 | 2014 | 189 | 0.110 |
Why?
|
Intraoperative Complications | 2 | 2015 | 1171 | 0.110 |
Why?
|
Obesity | 1 | 2016 | 13090 | 0.110 |
Why?
|
Confidence Intervals | 2 | 2013 | 2921 | 0.110 |
Why?
|
Homeostasis | 2 | 2016 | 3343 | 0.110 |
Why?
|
Hematoma, Subdural | 1 | 2014 | 128 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2013 | 23 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1223 | 0.100 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22351 | 0.100 |
Why?
|
Morpholines | 1 | 2016 | 584 | 0.100 |
Why?
|
Pedigree | 1 | 2021 | 4539 | 0.100 |
Why?
|
Hypertension | 3 | 2024 | 8616 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2019 | 16044 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2018 | 862 | 0.100 |
Why?
|
Hypoglycemia | 1 | 2020 | 896 | 0.100 |
Why?
|
Aminopyridines | 1 | 2016 | 577 | 0.100 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2022 | 277 | 0.100 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2012 | 21 | 0.100 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 706 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6514 | 0.100 |
Why?
|
Brain Stem Infarctions | 1 | 2012 | 31 | 0.100 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2012 | 53 | 0.100 |
Why?
|
Biometry | 1 | 2015 | 571 | 0.100 |
Why?
|
Postoperative Period | 1 | 2017 | 1824 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.100 |
Why?
|
Brain Injuries | 2 | 2022 | 2053 | 0.100 |
Why?
|
PubMed | 1 | 2012 | 129 | 0.090 |
Why?
|
Recurrence | 3 | 2021 | 8507 | 0.090 |
Why?
|
Pregnancy | 4 | 2022 | 30236 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11924 | 0.090 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1836 | 0.090 |
Why?
|
Species Specificity | 1 | 2015 | 2413 | 0.090 |
Why?
|
Sella Turcica | 1 | 2011 | 117 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2008 | 3511 | 0.090 |
Why?
|
Glasgow Coma Scale | 1 | 2013 | 574 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10384 | 0.090 |
Why?
|
Prospective Studies | 4 | 2024 | 54872 | 0.090 |
Why?
|
Orbital Neoplasms | 1 | 2013 | 223 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2016 | 935 | 0.090 |
Why?
|
Lung | 1 | 2009 | 10068 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2013 | 592 | 0.090 |
Why?
|
Troponin I | 1 | 2015 | 659 | 0.090 |
Why?
|
Child, Preschool | 7 | 2014 | 42577 | 0.090 |
Why?
|
Brain Stem Neoplasms | 1 | 2012 | 191 | 0.090 |
Why?
|
Survival Rate | 2 | 2015 | 12826 | 0.090 |
Why?
|
Brain Stem | 2 | 2012 | 858 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2978 | 0.080 |
Why?
|
History, 21st Century | 2 | 2013 | 1574 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
Telomerase | 1 | 2015 | 750 | 0.080 |
Why?
|
RNA | 1 | 2019 | 2715 | 0.080 |
Why?
|
Brain Edema | 2 | 2012 | 601 | 0.080 |
Why?
|
Risk Management | 1 | 2013 | 558 | 0.080 |
Why?
|
Fluid Therapy | 1 | 2013 | 587 | 0.080 |
Why?
|
Capillaries | 1 | 2012 | 755 | 0.080 |
Why?
|
Hematoma | 2 | 2012 | 766 | 0.080 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.080 |
Why?
|
Sex Factors | 2 | 2013 | 10619 | 0.080 |
Why?
|
Fluoroscopy | 1 | 2013 | 948 | 0.080 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2012 | 278 | 0.080 |
Why?
|
Pituitary Gland | 1 | 2011 | 635 | 0.080 |
Why?
|
Antioxidants | 1 | 2017 | 1671 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10451 | 0.080 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 649 | 0.080 |
Why?
|
Neural Conduction | 1 | 2010 | 442 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2392 | 0.080 |
Why?
|
Radiotherapy | 1 | 2015 | 1497 | 0.080 |
Why?
|
American Heart Association | 2 | 2023 | 1049 | 0.080 |
Why?
|
Glasgow Outcome Scale | 2 | 2005 | 101 | 0.080 |
Why?
|
Social Class | 1 | 2017 | 2007 | 0.080 |
Why?
|
Pleural Neoplasms | 1 | 2013 | 584 | 0.080 |
Why?
|
Spinal Cord Neoplasms | 1 | 2010 | 263 | 0.070 |
Why?
|
Medically Uninsured | 1 | 2013 | 838 | 0.070 |
Why?
|
Functional Laterality | 1 | 2015 | 2244 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4853 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6896 | 0.070 |
Why?
|
Creatinine | 1 | 2013 | 1917 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14762 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 701 | 0.070 |
Why?
|
Receptor, TIE-2 | 1 | 2008 | 183 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1804 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2060 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6779 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2023 | 14473 | 0.070 |
Why?
|
Benzylamines | 1 | 2008 | 251 | 0.070 |
Why?
|
Skull Base Neoplasms | 1 | 2010 | 280 | 0.070 |
Why?
|
Heterocyclic Compounds | 1 | 2008 | 245 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6225 | 0.070 |
Why?
|
Reoperation | 1 | 2017 | 4325 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10745 | 0.070 |
Why?
|
Drainage | 2 | 2022 | 1182 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2008 | 457 | 0.060 |
Why?
|
Meningeal Neoplasms | 1 | 2015 | 1255 | 0.060 |
Why?
|
Patient Selection | 2 | 2010 | 4252 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2006 | 192 | 0.060 |
Why?
|
Neuroradiography | 1 | 2005 | 71 | 0.060 |
Why?
|
Cell Hypoxia | 1 | 2008 | 661 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3885 | 0.060 |
Why?
|
Specialties, Nursing | 1 | 2005 | 10 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2887 | 0.060 |
Why?
|
Aortic Valve | 1 | 2015 | 1966 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2016 | 1292 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 547 | 0.060 |
Why?
|
Pericytes | 1 | 2008 | 298 | 0.060 |
Why?
|
Transduction, Genetic | 1 | 2008 | 899 | 0.060 |
Why?
|
Otolaryngology | 1 | 2012 | 699 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2520 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2008 | 921 | 0.060 |
Why?
|
Phosphoproteins | 3 | 2016 | 2448 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2006 | 748 | 0.060 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2005 | 62 | 0.060 |
Why?
|
Electromyography | 1 | 2010 | 1398 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 559 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2013 | 1958 | 0.060 |
Why?
|
Pupil | 1 | 2005 | 147 | 0.060 |
Why?
|
Infant | 4 | 2014 | 36459 | 0.060 |
Why?
|
Zygoma | 1 | 2004 | 52 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1883 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2005 | 265 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1892 | 0.060 |
Why?
|
Angiopoietin-2 | 1 | 2005 | 186 | 0.060 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2023 | 31 | 0.060 |
Why?
|
Parahippocampal Gyrus | 1 | 2004 | 117 | 0.050 |
Why?
|
Blotting, Western | 2 | 2008 | 5022 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2008 | 729 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 276 | 0.050 |
Why?
|
Mesencephalon | 1 | 2005 | 337 | 0.050 |
Why?
|
Cranial Fossa, Anterior | 1 | 2022 | 13 | 0.050 |
Why?
|
California | 1 | 2007 | 1435 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 616 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4858 | 0.050 |
Why?
|
Light | 2 | 2005 | 1358 | 0.050 |
Why?
|
Blood-Brain Barrier | 2 | 2006 | 1028 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6853 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1659 | 0.050 |
Why?
|
Evoked Potentials, Motor | 1 | 2005 | 463 | 0.050 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1324 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3850 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11062 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5990 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6408 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10863 | 0.050 |
Why?
|
Neostigmine | 1 | 2021 | 68 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4349 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2018 | 1838 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5888 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4570 | 0.040 |
Why?
|
Random Allocation | 1 | 2005 | 2394 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2004 | 913 | 0.040 |
Why?
|
Stroke Volume | 1 | 2015 | 5618 | 0.040 |
Why?
|
Orbit | 1 | 2004 | 459 | 0.040 |
Why?
|
Algorithms | 2 | 2022 | 14073 | 0.040 |
Why?
|
Endoscopy | 1 | 2010 | 1854 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5795 | 0.040 |
Why?
|
Polyvinyls | 1 | 2021 | 153 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9514 | 0.040 |
Why?
|
Dimethyl Sulfoxide | 1 | 2021 | 250 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8540 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2730 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2846 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7841 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2022 | 559 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2714 | 0.040 |
Why?
|
Observer Variation | 1 | 2005 | 2614 | 0.040 |
Why?
|
Massachusetts | 1 | 2012 | 8890 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4880 | 0.040 |
Why?
|
Gene Expression | 1 | 2011 | 7585 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1368 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 947 | 0.040 |
Why?
|
China | 1 | 2024 | 2386 | 0.040 |
Why?
|
Monocytes | 1 | 2008 | 2599 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 540 | 0.040 |
Why?
|
Cell Survival | 1 | 2008 | 5749 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4914 | 0.040 |
Why?
|
Transcription Factors | 2 | 2015 | 12159 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2815 | 0.040 |
Why?
|
Thrombectomy | 1 | 2022 | 676 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2008 | 5890 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2011 | 12430 | 0.040 |
Why?
|
Hypnotics and Sedatives | 1 | 2005 | 1193 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 13036 | 0.030 |
Why?
|
Angiography | 1 | 2022 | 1595 | 0.030 |
Why?
|
Skull | 1 | 2021 | 819 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26309 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2007 | 26387 | 0.030 |
Why?
|
Antigens, CD | 1 | 2007 | 4033 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4282 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
Amygdala | 1 | 2004 | 1375 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13644 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2021 | 603 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4968 | 0.030 |
Why?
|
History, 20th Century | 2 | 2012 | 2764 | 0.030 |
Why?
|
Longevity | 1 | 2022 | 1083 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 630 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 730 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15564 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2018 | 619 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1656 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 18076 | 0.030 |
Why?
|
Artifacts | 1 | 2022 | 1897 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1010 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23618 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1478 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2012 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2006 | 7869 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 716 | 0.020 |
Why?
|
Collagenases | 1 | 2012 | 221 | 0.020 |
Why?
|
Hippocampus | 1 | 2004 | 3776 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2012 | 697 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2012 | 161 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2013 | 656 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2413 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2005 | 20146 | 0.020 |
Why?
|
Cerebral Veins | 1 | 2011 | 157 | 0.020 |
Why?
|
Models, Statistical | 2 | 2015 | 5092 | 0.020 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2013 | 354 | 0.020 |
Why?
|
Brain Mapping | 1 | 2005 | 6597 | 0.020 |
Why?
|
Sphenoid Bone | 1 | 2010 | 176 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21162 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 2012 | 513 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3605 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2050 | 0.020 |
Why?
|
Nose | 1 | 2010 | 522 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1405 | 0.020 |
Why?
|
Rats | 2 | 2017 | 23717 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6306 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3621 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2902 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1195 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2210 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2598 | 0.020 |
Why?
|
Haplotypes | 1 | 2012 | 2726 | 0.020 |
Why?
|
Lac Operon | 1 | 2005 | 237 | 0.020 |
Why?
|
Jugular Veins | 1 | 2006 | 211 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8310 | 0.020 |
Why?
|
Perioperative Care | 1 | 2012 | 1043 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3440 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2823 | 0.010 |
Why?
|
Hemiplegia | 1 | 2005 | 137 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2012 | 1389 | 0.010 |
Why?
|
Ophthalmoplegia | 1 | 2005 | 168 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5795 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4926 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12985 | 0.010 |
Why?
|
Intracranial Hypertension | 1 | 2005 | 191 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3799 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3226 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5330 | 0.010 |
Why?
|
Adenoviridae | 1 | 2005 | 1093 | 0.010 |
Why?
|
Microcirculation | 1 | 2005 | 1282 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2005 | 1736 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2085 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8728 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2629 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9613 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1730 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15425 | 0.010 |
Why?
|
Equipment Design | 1 | 2005 | 3488 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9407 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8108 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3681 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 30214 | 0.010 |
Why?
|